Mizuho raises target for Cardinal Health stock to USD 280

Published on 10/22/2026 at 12:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mizuho lifted its target from USD 250.00 to USD 280.00 on October 20, 2026. Cardinal Health stock costs EUR 229.60 on October 22, 2026.

Capital allocation and reporting dates

Mizuho lifted its Cardinal Health target from USD 250.00 to USD 280.00 on October 20, 2026.
Fiscal 2026 revenue reached USD 254.0 billion after growing 14 percent.
Cardinal Health stock trades at EUR 229.60 at 12:29 p.m. CEST at Lang & Schwarz on October 22, 2026.
Fiscal 2027 first-quarter results are scheduled for November 5, 2026.

Belebtes NYSE-Handelsparkett mit Healthcare-Sektor-Anzeigetafeln und Tradern — NYSE-Börsenparkett mit Healthcare-Charts zeigt Cardinal Health Inc. Aktienhandel live – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) was trading at EUR 229.60 at Lang & Schwarz on October 22, 2026 at 12:29 p.m. CEST. Mizuho raised its price target from USD 250.00 to USD 280.00 and kept an Outperform rating on October 20, 2026, as MarketBeat reported. The target change puts capital allocation and fiscal 2027 execution at the center of the stock story.

Why the target moved to USD 280

Mizuho's target change followed Cardinal Health's fourth-quarter fiscal 2026 results and outlook. The company reported USD 63.7 billion of quarterly revenue and USD 2.91 in diluted earnings per share, while consensus earnings per share stood at USD 2.42, according to MarketBeat. Revenue increased 5.8 percent year over year, but the reported figure was below the USD 65.15 billion analyst estimate.

Management's fiscal 2027 guidance calls for adjusted earnings per share of USD 12.40 to USD 12.60. The earnings call also highlighted USD 5.0 billion of adjusted free cash flow in fiscal 2026 and a new USD 5.0 billion increase in the share repurchase authorization, taking total authorization to USD 6.4 billion, as Yahoo Finance reported on the August 11, 2026 call.

Three dates define the setup

On October 30, 2025, Cardinal Health reported first-quarter fiscal 2026 revenue of USD 64.0 billion and raised its outlook, according to the company's Cardinal Health newsroom. On August 11, 2026, fourth-quarter revenue reached USD 63.7 billion and fiscal 2026 revenue reached USD 254.0 billion. On October 20, 2026, Mizuho lifted its target to USD 280.00.

What dates come next?

Cardinal Health plans to release first-quarter fiscal 2027 results on November 5, 2026, before trading opens on the New York Stock Exchange, according to the company's October 1, 2026 announcement. The scheduled report will test whether the company can convert its fiscal 2027 adjusted earnings per share guidance of USD 12.40 to USD 12.60 into early-year execution.

Valuation and capital return

Cardinal Health's market capitalization was USD 59.6 billion as of October 21, 2026. Its primary exchange is the New York Stock Exchange, and the quoted 52-week range was USD 158.70 to USD 259.09 on that date. The range places the latest US quotation near its upper boundary, while the Mizuho target emphasizes expectations for continued earnings growth and shareholder returns.

Cardinal Health stock at Lang & Schwarz

Cardinal Health was trading at EUR 229.60 at Lang & Schwarz on October 22, 2026 at 12:29 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.